UBS Group
STJ

UBS Group’s St Jude Medical STJ Stock Holding History

UBS Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-27,100
Closed -$1.76M – 9840
2014
Q4 		$1.76M Buy
+27,100
New +$1.75M ﹤0.01% 3022

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

UBS Group's STJ Position: Q1 2017 in Review

UBS Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,343,476 shares — an estimated $108M sold.

UBS Group first reported a position in STJ in Q4 2014 and held it in 9 quarters. The position peaked at $178M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • UBS Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • UBS Group sold 1,343,476 St Jude Medical shares in Q1 2017, an estimated $108M.
  • UBS Group first reported a position in St Jude Medical in Q4 2014 and held it in 9 quarters.
  • UBS Group's St Jude Medical position peaked at $178M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.